CONTEXT THERAPEUTICS INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
CONTEXT THERAPEUTICS INC. (CNTX) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-23
- CONTEXT THERAPEUTICS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- CONTEXT THERAPEUTICS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- CONTEXT THERAPEUTICS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- CONTEXT THERAPEUTICS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-23 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |